NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RTM Vital Signs

RTM Vital Signs

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://rtmvitalsigns.com/

Last Round

Grant

Feb 1, 2024

Est. Valuation

$9.5M

Total Funding Raised

$1.95M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RTM Vital Signs is a medical device company that develops real-time continuous monitors for vital signs, focusing on cardiac and respiratory function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

wearable respiratory monitoringcontinuous respiratory monitoringrespiratory depression monitoringpatient monitoringmedical AIremote patient monitoringremote therapeutic monitoringRTMvital sign monitoringacoustic sensorpost-operative monitoringpredictive alertshealth IoTmedical deviceFDA 510(k)implantable cardiac monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RTM Vital Signs Comparables

Compare RTM Vital Signs with similar companies based on industry and business-model similarity.

RTM Vital Signs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Linshom Medical, Inc.
87%
Strados Labs
81%
GE HealthCare Technologies Inc.
69%

RTM Vital Signs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2024
GrantSep 1, 2023
SeedNov 1, 2020
GrantApr 1, 2020

RTM Vital Signs Investors

Notable investors and investment history

RTM Vital Signs investors
InvestorRounds
NIH RADxGrant
CAV AngelsSeed
Citizens Financial Group, Inc.Grant
National Institute on Drug AbuseGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 37% MoM.

  • May 2, 2025

    Monthly visitors increased 60% MoM.

RTM Vital Signs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RTM Vital Signs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RTM Vital Signs's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range5
Year Founded2014
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.